HRT Litigation: Resoundingly Positive
Monday, October 22nd, 2007
A staggering $99 million dollar verdict was returned in Reno, Nevada last week on behalf of 3 women who claim they contracted breast cancer as a result of being prescribed Premarin and Prempro- both estrogenic preparations manufactured by Wyeth. Both compensatory damages for pain and suffering, and punitive damages arising from the company’s fraud and negligence were at the heart of this groundbreaking result.
Plaintiff attorneys and thousands of women have been maintaining, since the NIH’s pivotal findings in the Women’s Health Initiative in 1992, that hormonal compounds for menopausal symptoms have been aggressively and fraudulently marketed for long term use for many years despite the fact that these drugs are carcinogenic and were never studied (by the companies raking in millions in profits) for this potential health.